Drug Shortage Report for TEVA-TRIACOMB
Report ID | 153153 |
Drug Identification Number | 00550507 |
Brand name | TEVA-TRIACOMB |
Common or Proper name | TRIACOMB CREAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | GRAMICIDIN NEOMYCIN NYSTATIN TRIAMCINOLONE ACETONIDE |
Strength(s) | 0.25MG 2.5MG 100000UNIT 1MG |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 30G |
ATC code | D07CB |
ATC description | CORTICOSTEROIDS, COMB WITH ANTIBIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-19 |
Estimated end date | 2023-07-30 |
Actual end date | 2023-07-13 |
Shortage status | Resolved |
Updated date | 2023-07-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2022-12-01 | English | Compare |
v22 | 2022-12-01 | French | Compare |
v23 | 2023-02-02 | English | Compare |
v24 | 2023-02-02 | French | Compare |
v25 | 2023-04-27 | English | Compare |
v26 | 2023-04-27 | French | Compare |
v27 | 2023-07-05 | English | Compare |
v28 | 2023-07-05 | French | Compare |
v29 | 2023-07-13 | English | Compare |
v30 | 2023-07-13 | French | Compare |
v31 | 2023-07-14 | English | Compare |